Clinical Trial Information

Connecting people, advancing clinical value

Korea Clinical Trial Requirements: A Step-by-Step Guide for Global Companies

Korea Clinical Trial Requirements: A Step-by-Step Guide for Global Companies

2025/12/24
Read more
MFDS Fast‑Track 2026: Navigating GIFT Korea, Priority Review & Conditional Approval

MFDS Fast‑Track 2026: Navigating GIFT Korea, Priority Review & Conditional Approval

2025/12/17
Read more
2026 ADC Clinical Trial Trends: From HER2‑Low to TROP‑2 and Korea’s Opportunity

2026 ADC Clinical Trial Trends: From HER2‑Low to TROP‑2 and Korea’s Opportunity

2025/12/10
Read more
Top 5 Best‑Selling Drugs in 2025 and Why Korea Is a Strategic Clinical Trial Hub

Top 5 Best‑Selling Drugs in 2025 and Why Korea Is a Strategic Clinical Trial Hub

2025/12/03
Read more
Korea Clinical Trial Strategy After MFDS 2025 Reforms: Why Korea is Becoming a Strategic Hub

Korea Clinical Trial Strategy After MFDS 2025 Reforms: Why Korea is Becoming a Strategic Hub

2025/11/26
Read more
2026 MFDS IND Approval Trends and Triple‑Agonist Clinical Trial Strategies in Korea

2026 MFDS IND Approval Trends and Triple‑Agonist Clinical Trial Strategies in Korea

2025/11/19
Read more
Five Pillars for Global Submission Readiness

Clinical Research Management in the WLA Era: Five Pillars for Global Submission Readiness

2025/11/12
Read more
2025 Korea CDx Co‑Development Guide- Latest Regulations and Submission Strategies

2025 Korea CDx Co‑Development Guide: Latest Regulations and Submission Strategies

2025/11/05
Read more
ADC Clinical Trials in Korea- Drug Conjugates and Value of Domestic CROs_

ADC Clinical Trials in Korea:Drug Conjugates and Value of Domestic CROs

2025/10/29
Read more